PHOTACs enable optical control of protein degradation.

TitlePHOTACs enable optical control of protein degradation.
Publication TypeJournal Article
Year of Publication2020
AuthorsReynders M, Matsuura BS, BĂ©routi M, Simoneschi D, Marzio A, Pagano M, Trauner D
JournalSci Adv
Volume6
Issue8
Paginationeaay5064
Date Published2020 02
ISSN2375-2548
KeywordsCell Line, Tumor, Humans, Light, Optical Phenomena, Proteolysis, Tacrolimus Binding Protein 1A
Abstract

PROTACs (PROteolysis TArgeting Chimeras) are bifunctional molecules that target proteins for ubiquitylation by an E3 ligase complex and subsequent degradation by the proteasome. They have emerged as powerful tools to control the levels of specific cellular proteins. We now introduce photoswitchable PROTACs that can be activated with the spatiotemporal precision that light provides. These trifunctional molecules, which we named PHOTACs (PHOtochemically TArgeting Chimeras), consist of a ligand for an E3 ligase, a photoswitch, and a ligand for a protein of interest. We demonstrate this concept by using PHOTACs that target either BET family proteins (BRD2,3,4) or FKBP12. Our lead compounds display little or no activity in the dark but can be reversibly activated with different wavelengths of light. Our modular approach provides a method for the optical control of protein levels with photopharmacology and could lead to new types of precision therapeutics that avoid undesired systemic toxicity.

DOI10.1126/sciadv.aay5064
Alternate JournalSci Adv
PubMed ID32128406
PubMed Central IDPMC7034999
Grant ListR01 CA076584 / CA / NCI NIH HHS / United States
S10 OD016343 / OD / NIH HHS / United States
T32 CA009161 / CA / NCI NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States
Related Faculty: 
Antonio Marzio, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700